Clinical Pharmacology in Drug Development

SJR Rank #10,719H-index: 42SJR: 0.553Best quartile: Q2APC: US$3,800
Journal website: aims, scope and author guidelines
Publisher

Wiley-Blackwell

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pharmaceutical ScienceQ2
  • Pharmacology (medical)Q3

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmaceutical studies and practicesPharmacogenetics and Drug MetabolismDiabetes Treatment and ManagementDrug Transport and Resistance MechanismsChronic Lymphocytic Leukemia ResearchHIV/AIDS drug development and treatmentPharmacological Effects and Toxicity StudiesAntibiotics Pharmacokinetics and EfficacyDiverse Scientific and Economic StudiesStatistical Methods in Clinical Trials

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504080120160

Detailed Information

ISSN

2160-7648, 2160-763X

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

1.71

References per Document

22.53

Coverage

2012-2026

Scope

Clinical Pharmacology in Drug Development is an international, peer-reviewed, online publication focused on publishing high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in early development phases in healthy subjects. Acceptance of a manuscript in Clinical Pharmacology in Drug Development will be determined by scientific rigor and technical soundness rather than perceived importance of the presented results. Thus, negative study results are explicitly not an obstacle for positive acceptance decisions.

Metrics from SCImago Journal Rank 2025. View on SCImago